Healthcare provider profile · identity verified

Girish C Joshi, MD

Family Practice · SOMERSWORTH, NH · NPI 1316993728

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	350	104
Lisinopril	Lisinopril	316	91
Omeprazole	Omeprazole	213	70
Rosuvastatin Calcium	Rosuvastatin Calcium	206	69
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	205	31
Lorazepam	Lorazepam	202	46
Amlodipine Besylate	Amlodipine Besylate	194	56
Levothyroxine Sodium	Levothyroxine Sodium	175	50
Zolpidem Tartrate	Zolpidem Tartrate	155	28
Metoprolol Succinate	Metoprolol Succinate	147	41
Pantoprazole Sodium	Pantoprazole Sodium	142	42
Hydrochlorothiazide	Hydrochlorothiazide	134	39
Chlorthalidone	Chlorthalidone	125	44
Metformin Hcl Er	Metformin Hcl	122	31
Losartan Potassium	Losartan Potassium	120	37
Gabapentin	Gabapentin	112	27
Clonazepam	Clonazepam	109	15
Allopurinol	Allopurinol	108	26
Albuterol Sulfate Hfa	Albuterol Sulfate	101	42
Tamsulosin Hcl	Tamsulosin Hcl	93	30
Ozempic	Semaglutide	88	15
Glimepiride	Glimepiride	81	26
Fluoxetine Hcl	Fluoxetine Hcl	76	24
Simvastatin	Simvastatin	74	19
Irbesartan	Irbesartan	71	18
Alprazolam	Alprazolam	69	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	69	22
Jardiance	Empagliflozin	68	13
Furosemide	Furosemide	66	21
Metformin Hcl	Metformin Hcl	61	19
Tramadol Hcl	Tramadol Hcl	60	25
Methylprednisolone	Methylprednisolone	59	42
Venlafaxine Hcl Er	Venlafaxine Hcl	59	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	58	suppressed
Ipratropium Bromide	Ipratropium Bromide	54	23
Carvedilol	Carvedilol	53	15
Testosterone Cypionate	Testosterone Cypionate	52	suppressed
Eliquis	Apixaban	50	13
Potassium Chloride	Potassium Chloride	49	18
Cefpodoxime Proxetil	Cefpodoxime Proxetil	44	34
Oxycodone Hcl	Oxycodone Hcl	44	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	41	34
Lamotrigine	Lamotrigine	41	suppressed
Trazodone Hcl	Trazodone Hcl	41	11
Levofloxacin	Levofloxacin	40	24
Xarelto	Rivaroxaban	40	11
Metoprolol Tartrate	Metoprolol Tartrate	39	12
Pravastatin Sodium	Pravastatin Sodium	38	12
Sertraline Hcl	Sertraline Hcl	38	suppressed
Bupropion Xl	Bupropion Hcl	36	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	35	25
Mupirocin	Mupirocin	33	26
Prednisone	Prednisone	33	12
Meloxicam	Meloxicam	32	15
Valacyclovir	Valacyclovir Hcl	31	11
Mounjaro	Tirzepatide	30	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Ibuprofen	Ibuprofen	29	suppressed
Nebivolol Hcl	Nebivolol Hcl	29	suppressed
Clopidogrel	Clopidogrel Bisulfate	28	suppressed
Famotidine	Famotidine	28	11
Duloxetine Hcl	Duloxetine Hcl	27	suppressed
Sodium Chloride	0.9 % Sodium Chloride	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Topiramate	Topiramate	24	suppressed
Fluconazole	Fluconazole	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Atenolol	Atenolol	22	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	22	suppressed
Montelukast Sodium	Montelukast Sodium	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Naproxen	Naproxen	20	suppressed
Lovastatin	Lovastatin	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	11
Triamcinolone Acetonide	Triamcinolone Acetonide	19	15
Warfarin Sodium	Warfarin Sodium	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	13
Valsartan	Valsartan	18	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	18	suppressed
Azithromycin	Azithromycin	17	14
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Nitroglycerin	Nitroglycerin	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Modafinil	Modafinil	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Diazepam	Diazepam	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Atrovent Hfa	Ipratropium Bromide	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Finasteride	Finasteride	13	suppressed
Fluticasone Propionate	Fluticasone Propionate	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Oxycontin	Oxycodone Hcl	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Ambien Cr	Zolpidem Tartrate	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Clindamycin Hcl	Clindamycin Hcl	12	suppressed
Primidone	Primidone	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Spironolactone	Spironolactone	11	suppressed
Torsemide	Torsemide	11	suppressed
Trintellix	Vortioxetine Hydrobromide	11	suppressed
Xifaxan	Rifaximin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error